Turnstone Biologics
turnstonebio.comLocations
San Francisco, CA, USA
Bio & pharma
takeda
orbimed
f-prime capital
northleaf capital partners
Point72
2. 11-50
Turnstone’s platform and intellectual property are based on discoveries from leading researchers in the oncolytic viral immunotherapy field including John Bell, Ph.D., Brian Lichty, Ph.D., and David Stojdl, Ph.D. Four Canadian academic institutes, together with the Fight Against Cancer Innovation Trust (FACIT), have advanced Turnstone’s lead immunotherapy product into a Phase I/II clinical development study in advanced cancer patients.
Something looks off?Open jobs at Turnstone Biologics